Which REM Sleep Behavior Disorder Patients Will Develop Parkinson’s? CND Works on Skin Biopsy Test for Early Detection of Synucleinopathies
CND Life Sciences is studying its Syn-One Test in hopes of predicting the conversion of RBD to a more advanced synucleinopathy.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
